Pharmacokinetics of tenvermectin in swine, a novel antiparasitic drug candidate—comparison with ivermectin
Open Access
- 11 February 2023
- journal article
- research article
- Published by Wiley in Veterinary Medicine and Science
- Vol. 9 (3) , 1211-1216
Abstract
Tenvermectin (TVM) is a novel 16‐membered macrolide compound isolated and purified from the fermentation broth of genetically engineered Streptomyces avermitilis strain MHJ1011. TVM and ivermectin were administered at the dose of 0.3 mg/kg body weight through a single subcutaneous injection route followed by plasma collectiom and analysis at different time intervals. Plasma concentrations of TVM and IVM were determined by high‐performance liquid chromatography with fluorescence detector. Pharmacokinetic analysis was completed using the non‐compartmental method with WinNonlin™ 6.4 software. TVM is rapidly absorbed after administration with peak plasma concentrations (Cmax, 9.78 ± 2.34 ng/ml) obtained within 6–22 h. AUC0‐last was 586.86 h·ng/ml ± 121.24 h·ng/ml. The mean elimination half‐life of TVM (T1/2λz) was 97.99 h ± 46.41 h. The T1/2λz of IVM was 146.59 h ± 22.26 h in the study. The present study showed that subcutaneous administration of TVM at 0.3 mg/kg body weight (BW) in swine is absorbed more rapidly than IVM in swine. Compared to the pharmacokinetic characteristics of IVM, there was little difference in the half‐life of TVM among different individuals. The data will contribute to refining the formulation and dosage regime for TVM administration.Keywords
Funding Information
- National Natural Science Foundation of China (32060812)
This publication has 28 references indexed in Scilit:
- Gene Replacement for the Generation of Designed Novel Avermectin Derivatives with Enhanced Acaricidal and Nematicidal ActivitiesApplied and Environmental Microbiology, 2015
- Pharmacokinetic Features of the Antiparasitic Macrocyclic LactonesCurrent Pharmaceutical Biotechnology, 2012
- Treatment of Human Disseminated Strongyloidiasis with a Parenteral Veterinary Formulation of IvermectinClinical Infectious Diseases, 2005
- Direct production of ivermectin-like drugs after domain exchange in the avermectin polyketide synthase of Streptomyces avermitilis ATCC31272Organic & Biomolecular Chemistry, 2003
- Does the rate of fat deposition influence the pharmacokinetic disposition of subcutaneously administered moxidectin and ivermectin in pigs?Journal of Veterinary Pharmacology and Therapeutics, 2002
- Bioequivalence of ivermectin formulations in pigs and cattleJournal of Veterinary Pharmacology and Therapeutics, 1999
- Effect of formulation on the pharmacokinetics and efficacy of doramectinVeterinary Parasitology, 1993
- The distribution and some pharmacokinetic parameters of ivermectin in pigsVeterinary Research Communications, 1992
- Liquid chromatographic determination of ivermectin in animal plasma with trifluoroacetic anhydride and N-methylimidazole as the derivatization reagentJournal of Pharmaceutical and Biomedical Analysis, 1990
- Pharmacokinetic studies of ivermectin: Effects of formulationVeterinary Research Communications, 1985